RECRUITING

Time-restricted Eating Versus Daily Continuous Calorie Restriction on Body Weight and Colorectal Cancer Risk Markers

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

Approximately 42% of American adults are obese, and this condition is strongly related to the development of colorectal cancer. Innovative lifestyle strategies to treat obesity and reduce colorectal cancer risk are critically needed. This research will demonstrate that time-restricted eating, a type of intermittent fasting, is an effective therapy to help obese individuals reduce and control their body weight and prevent the development of colorectal cancer.

Official Title

Effects of Time-restricted Eating Versus Daily Continuous Calorie Restriction on Body Weight and Colorectal Cancer Risk Markers Among Adults With Obesity

Quick Facts

Study Start:2022-05-17
Study Completion:2026-09
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05114798

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:45 Years to 70 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. 1. 45-70 years old,
  2. 2. BMI 30-49.99 kg/m2
  3. 3. Are up to date with CRC screening.
  1. 1. Have a history of renal disease, autoimmune disorders, immunodeficiency, malabsorptive disorder, significant gastrointestinal and hepatic disease, surgical change in gastrointestinal anatomy, severe ischemic heart disease, severe pulmonary disease, severe mental health disorder, eating disorder, or bariatric surgery;
  2. 2. Abuse alcohol (\> 50 grams/day), illicit drugs (other than self-reported marijuana use), or use combustible tobacco;
  3. 3. Have controlled type 2 diabetes or undiagnosed uncontrolled diabetes based on hemoglobin A1c (HbA1c) \> 9.0%;
  4. 4. Have a history of cancer treatment within the past 12 months, CRC, genetic predisposition to CRC (e.g., Lynch syndrome);
  5. 5. Have a baseline body weight \> 450 lbs (weight limitation of the DXA);
  6. 6. Are on a weight loss diet or actively involved in a formal weight loss program (e.g., Weight Watchers);
  7. 7. Are not weight stable for 3 months prior to the study (weight gain or loss \> 4 kg);
  8. 8. Are unable to keep a food diary for 7 consecutive days during screening;
  9. 9. Are night shift workers;
  10. 10. Are pregnant or trying to get pregnant;
  11. 11. Are taking drugs that influence study outcomes (weight loss medications);
  12. 12. Are non-English speaking
  13. 13. Are taking anticoagulant medications or medications with endoscopic risk
  14. 14. Are taking antivirals or immunosuppressant medications
  15. 15. Don't have regular access to an email address and computer/smartphone/tablet
  16. 16. Are currently following a diet that requires fasting on a weekly basis
  17. 17. Currently eat for less than 10 hours of the day (determined by asking participants what time they start and stop eating on a usual day)

Contacts and Locations

Study Contact

Lisa Tussing-Humphreys, PhD, MS, RD
CONTACT
312-355-5521
ltussing@uic.edu
Krista Varady, PhD
CONTACT
312-996-7897
varady@uic.edu

Principal Investigator

Lisa Tussing-Humphreys, PhD, MS, RD
PRINCIPAL_INVESTIGATOR
University of Illinois at Chicago

Study Locations (Sites)

University of Illinois at Chicago
Chicago, Illinois, 60612
United States

Collaborators and Investigators

Sponsor: University of Illinois at Chicago

  • Lisa Tussing-Humphreys, PhD, MS, RD, PRINCIPAL_INVESTIGATOR, University of Illinois at Chicago

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2022-05-17
Study Completion Date2026-09

Study Record Updates

Study Start Date2022-05-17
Study Completion Date2026-09

Terms related to this study

Additional Relevant MeSH Terms

  • Time Restricted Eating
  • Obesity
  • Weight Loss
  • Colorectal Cancer